FdaApplication
ANDA 210611
Identifiers
- fda_app_no: ANDA210611
Properties
| Property | Value |
|---|---|
| applicant_name | NOVAST LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2019-10-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET;ORAL |
1 product